Safety and efficacy in actual clinical practice of once-weekly subcutaneous teriparatide for osteoporosis patients with a high fracture risk

DOI: 10.1016/j.afos.2019.06.002

Keywords: Osteoporosis, Teriparatide, Once-weekly administration, Postmarketing

Full-Text   Cite this paper   Add to My Lib

Abstract:

To reassess the safety and efficacy of once-weekly teriparatide 56.5？μg in osteoporosis patients with a high fracture risk

Full-Text